91Â鶹ÌìÃÀÖ±²¥

Skip to main content
Christopher B. Dechet
( out of 322 reviews )

Christopher B. Dechet, MD, FACS

Languages spoken: German, English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Clinic 2B, Urology
Salt Lake City
801-587-4383
  • Christopher Dechet, MD, FACS is an Professor in the Division of Urology, Department of Surgery at the University of Utah. He currently serves as the Co-director of the Multidisciplinary Urologic Oncology Group at the Huntsman Cancer Institute. Dr. Dechet specializes in the surgical care of patients with urologic cancers at the Huntsman Cancer Institute. His practice focuses on prostate, kidney, bladder, adrenal and testis cancer. His expertise encompasses robotic, laparoscopic, endoscopic, and open surgical approaches.

    Dr. Dechet has been using Da Vinci robotic system since 2004 and is the most experienced robotic surgeon in the Intermountain West. He routinely performs robotic prostatectomy, robotic partial nephrectomy and robotic cystectomy. Dr. Dechet also has extensive laparoscopic expertise having been awarded an achievement award from the Society of Laparoscopic Surgeons.

    Dr. Dechet has developed a comprehensive quality of life database for the purpose of improving surgical outcomes for prostate cancer. He has also developed a robotic surgical approach for treating patients with high risk prostate cancer.

    Besides prostatectomy, Dr. Dechet specializes in complex partial nephrectomies, renal cell with vena caval thrombus, post-chemotherapy retroperitoneal lymph node dissection and cystectomy with neobladder formation.

    Dr. Dechet received his undergraduate degree from Stanford University and earned a medical degree from the University of Pennsylvania, School of Medicine. He was the recipient of an American Heart Associate research grant during his medical training. He completed his surgery and urology training at the Mayo Clinic in Rochester, Minnesota.

    Over the past 20 years, Dr. Dechet has been the recipient of multiple awards, including the Patient Choice Physician Award, Most Compassionate Doctor Award, Vitals Top 10 Doctor Award, Vitals Top 10 Specialist and Top Urologist Award. He regularly give presentations throughout the world and has been a visiting professor in Italy and Austria, where he has performed nerve-sparing prostatectomy, robotic cystectomy and partial nephrectomy.

    Board Certification

    American Board of Urology

    Patient Rating

    4.9 /5
    ( out of 322 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    September 30, 2024
    HUNTSMAN CANCER CENTER

    Dr. Dechet is a leader in his field of treatment. I am very confident in his abilities.

    September 27, 2024
    HUNTSMAN CANCER CENTER

    Dr. Dechet is easy to talk to, he listens and responds to our discussion like a good friend. He inspires trust.

    September 26, 2024
    HUNTSMAN CANCER CENTER

    Dr. Dechet saved my life by removing a malignant kidney, stage 3, but contained. No further treatment.

    September 20, 2024
    HUNTSMAN CANCER CENTER

    Dr. Dechet and his staff are simply the high-bar standard of modern care. Up on technology. Deeply caring. And highly skilled. In Dr. Dechet and his team's hands, a patient has the best chance for success!

    September 20, 2024
    HUNTSMAN CANCER CENTER

    Best there is. I'm very Thankful to have opportunity to have first class healthcare at Huntsman Cancer Institute. Dr. Dechet Is absolutely the best.

    September 20, 2024
    HUNTSMAN CANCER CENTER

    I feel really fortunate to have a surgeon that is so skilled handling this procedure.

    September 17, 2024
    HUNTSMAN CANCER CENTER

    Very professional and very experienced.

    July 31, 2024
    HUNTSMAN CANCER CENTER

    Dr DECHET IS SO COOL HIS PROFESSIONAL SIDE AND HIS CARING SO BLESSED TO HAVE HIM IN MY JOURNEY AND PUTTING TIME BACK ON THE CLOCK FOR ME :)

    July 30, 2024
    HUNTSMAN CANCER CENTER

    Explained everything well and answered our concerns.

  • Christopher Dechet, MD, FACS is an Professor in the Division of Urology, Department of Surgery at the University of Utah. He currently serves as the Co-director of the Multidisciplinary Urologic Oncology Group at the Huntsman Cancer Institute. Dr. Dechet specializes in the surgical care of patients with urologic cancers at the Huntsman Cancer Institute. His practice focuses on prostate, kidney, bladder, adrenal and testis cancer. His expertise encompasses robotic, laparoscopic, endoscopic, and open surgical approaches.

    Dr. Dechet has been using Da Vinci robotic system since 2004 and is the most experienced robotic surgeon in the Intermountain West. He routinely performs robotic prostatectomy, robotic partial nephrectomy and robotic cystectomy. Dr. Dechet also has extensive laparoscopic expertise having been awarded an achievement award from the Society of Laparoscopic Surgeons.

    Dr. Dechet has developed a comprehensive quality of life database for the purpose of improving surgical outcomes for prostate cancer. He has also developed a robotic surgical approach for treating patients with high risk prostate cancer.

    Besides prostatectomy, Dr. Dechet specializes in complex partial nephrectomies, renal cell with vena caval thrombus, post-chemotherapy retroperitoneal lymph node dissection and cystectomy with neobladder formation.

    Dr. Dechet received his undergraduate degree from Stanford University and earned a medical degree from the University of Pennsylvania, School of Medicine. He was the recipient of an American Heart Associate research grant during his medical training. He completed his surgery and urology training at the Mayo Clinic in Rochester, Minnesota.

    Over the past 20 years, Dr. Dechet has been the recipient of multiple awards, including the Patient Choice Physician Award, Most Compassionate Doctor Award, Vitals Top 10 Doctor Award, Vitals Top 10 Specialist and Top Urologist Award. He regularly give presentations throughout the world and has been a visiting professor in Italy and Austria, where he has performed nerve-sparing prostatectomy, robotic cystectomy and partial nephrectomy.

    Board Certification and Academic Information

    Academic Departments Surgery -Primary
    Academic Divisions Urology
    Board Certification
    American Board of Urology

    Education history

    Residency Urology - Mayo Clinic Resident
    Surgery - Mayo Clinic Intern
    Professional Medical Medicine - University of Pennsylvania M.D.
    German Studies - Stanford University B.A.

    Selected Publications

    Journal Article

    1. Hutten R, Khouri A, Parsons M, Tward A, Wilson T, Peterson J, Morrell G, Dechet C, ONeil B, Schmidt B, Kokeny K, Lloyd S, Cannon D, Tward J, Sanchez A, Johnson S (2022). The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer. Clin Genitourin Cancer, 20(6), e453-e459. ()
    2. Slade AD, Cardinal JR, Martin CR, Presson AP, Allen CD, Lowrance WT, Dechet CB, ONeil BB (2021). Feasibility of wearable activity trackers in cystectomy patients to monitor for postoperative complications. Curr Urol, 15(4), 209-213. ()
    3. Hunt TC, Ambrose JP, Haaland B, Kawamoto K, Dechet CB, Lowrance WT, Hanson HA, ONeil BB (2021). Decision fatigue in low-value prostate cancer screening. Cancer, 127(18), 3343-3353. ()
    4. Greenberg SE, Hunt TC, Ambrose JP, Lowrance WT, Dechet CB, ONeil BB, Tward JD (2021). Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline Expansion. JCO Precis Oncol, 5. ()
    5. Tward JD, ONeil B, Boucher K, Kokeny K, Lowrance WT, Lloyd S, Cannon D, Stephenson RA, Agarwal N, Farr T, Petragallo R, Sherar NZ, Kunz I, Hofer A, Courdy S, Shrieve DC, Dechet C (2020). Metastasis, Mortality, and Quality of Life for Men With NCCN High and Very High Risk Localized Prostate Cancer After Surgical and/or Combined Modality Radiotherapy. Clin Genitourin Cancer, 18(4), 274-283.e5. ()
    6. Armstrong JM, Martin CR, Dechet C, Morton K, Evans D, Ambrose J, Maughan BL, ONeil B, Lowrance W (2020). 18F-fluciclovine PET CT detection of biochemical recurrent prostate cancer at specific PSA thresholds after definitive treatment. Urol Oncol, 38(7), 636.e1-636.e6. ()
    7. Hanson HA, Leiser CL, ONeil B, Martin C, Gupta S, Smith KR, Dechet C, Lowrance WT, Madsen MJ, Camp NJ (2020). Harnessing Population Pedigree Data and Machine Learning Methods to Identify Patterns of Familial Bladder Cancer Risk. Cancer Epidemiol Biomarkers Prev, 29(5), 918-926. ()
    8. Martin C, West JM, Palermo S, Patel DP, Presson AP, Comploj E, Pycha A, Hancock JB, Dechet CB, Trenti E (2019). Elderly patients undergoing cystectomy, comparing preoperative American Society of Anesthesiology and Eastern Cooperative Oncology Group scores and operative approaches. Urologia, 86(4), 183-188. ()
    9. Tward J, Boucher K, Kokeny K, Lowrance WT, Lloyd S, Dechet C, Cannon D, Stephenson R, Agarwal N, Farr T, Petragallo R, Sherar N, Kunz I, Hofer A, Courdy S, Shrieve D, ONeil B (2018). Optimal Radiation and Surgical Strategies to Reduce Disease Progression and Mortality of Men with NCCN High and Very High Risk Localized Prostate Cancer. Submitted:. JAMA.
    10. Comploj E, Dechet CB, Mian M, Trenti E, Palermo S, Lodde M, Mian C, Ambrosini-Spaltro A, Horninger W, Pycha A (2014). Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancer. World J Urol, 32(5), 1219-23. ()
    11. Mian C, Comploj E, Resnyak E, Trenti E, Palermo S, Lodde M, Pycha A, Ambrosini-Spaltro A, Dechet CB, Pycha A (2014). Long-term follow-up of intermediate-risk non-muscle invasive bladder cancer sub-classified by multi-coloured FISH. Anticancer Res, 34(6), 3067-71. ()
    12. ONeil BB, Presson A, Gannon J, Stephenson RA, Lowrance W, Dechet CB, Tward JD, Myers JB, Brant WO (2014). Climacturia after definitive treatment of prostate cancer. J Urol, 191(1), 159-63. ()
    13. Comploj E, Cassar W, Farina A, Gasparella P, Trenti E, Palermo S, Dechet CB, Caione P, Pycha A (2013). Conservative management of paediatric renal abscess. J Pediatr Urol, 9(6 Pt B), 1214-7. ()
    14. Friedhelm, B, Berner, L, Dechet C, Presson, A, Pycha, A (2013). Does the Surgeon have an Influence on Clinical Voiding Parameters and Postoperative Sexual Function after TURP? Aktuelle Urol, 44(5), 370-374.
    15. Hadley DA, Stephenson RA, Samlowski WE, Dechet CB (2011). Patterns of enlarged lymph nodes in patients with metastatic renal cell carcinoma. Urol Oncol, 29(6), 751-5. ()
    16. Greenlee JE, Clawson SA, Hill KE, Dechet CB, Carlson NG (2010). Antineuronal autoantibodies in paraneoplastic cerebellar degeneration associated with adenocarcinoma of the prostate. J Neurol Sci, 291(1-2), 74-8. ()
    17. Hansen PA, Dechet CB, Porucznik CA, LaStayo PC (2009). Comparing eccentric resistance exercise in prostate cancer survivors on and off hormone therapy: a pilot study. PM R, 1(11), 1019-24. ()
    18. Abel EJ, Masterson TA, Warner JN, Valentine K, Dechet CB (2009). Nerve-sparing prostatectomy and urinary function: a prospective analysis using validated quality-of-life measures. Urology, 73(6), 1336-1440.
    19. Abel EJ, Masterson TA, Warner JN, Valentine K, Dechet C (2009). Nerve-sparing prostatectomy and urinary function: a prospective analysis using validated quality-of-life measures. Urology, 73(6), 1336-40. ()
    20. Anker CJ, Dechet CB, Issac JC, Akerley W, Shrieve DC (2008). Small-Cell Carcinoma of the Prostate. J Clin Oncol, 26(7), 1168-1171.
    21. Dechet CB, Zincke H, Sebo TJ, King BF, LeRoy AJ, Farrow GM, Blute ML (2003). Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J Urol, 169(1), 71-4. ()
    22. Lindor NM, Dechet CB, Greene MH, Jenkins RB, Zincke MT, Weaver AL, Wilson M, Zincke H, Liu W (2001). Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population. Genet Test, 5(2), 101-6. ()
    23. Dechet CB, Sebo T, Farrow G, Blute ML, Engen DE, Zincke H (1999). Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults. J Urol, 162(4), 1282-4; discussion 1284-5. ()
    24. Dechet CB, Young MM, Segura JW (1999). Laparoscopic transureteroureterostomy: demonstration of its feasibility in swine. J Endourol, 13(7), 487-93. ()
    25. Dechet CB, Bostwick DG, Blute ML, Bryant SC, Zincke H (1999). Renal oncocytoma: multifocality, bilateralism, metachronous tumor development and coexistent renal cell carcinoma. J Urol, 162(1), 40-2. ()
    26. Dechet CB, Weller S, Benowitz L, Rossitch E (1994). Neurological and Histopathologic Outcome in a Highly Reproducible Model of Secondary Spinal Cord Injury in the Rat.

    Book Chapter

    1. Mayer E, Myers J, Dechet CB (2023). Urethrectomy. In Smith J, Howards S, Preminger G. (Eds.), Hinman's Atlas of Urologic Surgery (5th). Philadelphia: Elsevier Saunders.
    2. Luzny P amp, Dechet C (2016). Kidney Metastatic Bone Disease. In Randall's Metastatic Bone Disease: And Intergrated Approach to Patient Care (pp. 71-83). Springer New York Heidelberg Dordrecht London.
    3. Dechet CB (2012). Urethrectomy. In Frank Hinman's Atlas (Ed.), Hinman's Atlas of Urologic Surgery, 3rd Edition. Cleveland, Ohio: Hinman's Atlas of Urologic Surgery, 3rd Edition.
    4. Dechet CB, King B, Barrett D (2000). Radiology of Prosthesis for Urinary Incontinence. In Pollack and McClennan (Eds.), Clinical Urography (ed.2).

    Case Report

    1. Samlowski EE, Dechet CB, Weissman A, Samlowski WE (07/01/2011). Large cell non-Hodgkin's lymphoma masquerading as renal carcinoma with inferior vena cava thrombosis: a case report. J Med Case Rep, 5(1), 245.

    Video/Film/CD/Web/Podcast

    1. Barabas A, Dechet CB (2005). The use of the Lapara Ty to Reduce Warm Ischemic Times during Laparoscopic Partial Nephrectomy (video) [Video].